Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × tivozanib × Clear all

NCT01885949 2026-05-20

Tivozanib + Enzalutamide in Adv Prostate Cancer

Phase 2 Terminated

5 enrolled 8 charts

Neoplasm Metastasis, Prostatic Neoplasms